Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease:

Maryam Ahmadzadeh1,2,3, Gregory J Christie1,2,3, Theodore D Cosco4,5

  • 1Digital Health Hub, Simon Fraser University, 4190 Galleria 4, 250 - 13450 102 Ave, Surrey, BC, V3T 0A3, Canada.

Systematic Reviews
|April 4, 2020
PubMed
Abstract

Insights

Predicting Alzheimer's disease (AD) progression from mild cognitive impairment (MCI) is crucial. This review synthesizes recent neuroimaging and machine learning techniques to identify individuals likely to convert from MCI to AD dementia.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder impacting cognition and behavior.
  • Mild cognitive impairment (MCI) is an early stage of AD, but not all individuals with MCI progress to dementia.
  • Accurate prediction of MCI to AD progression is vital for developing interventions.

Purpose of the Study:

  • To review recent neuroimaging procedures for predicting MCI to AD dementia conversion.
  • To systematically discuss machine learning techniques used in predicting MCI conversion.

Main Methods:

  • Rapid review of studies published from January 1, 2017, to the search date.
  • Searched PubMed, SCOPUS, and Web of Science for relevant randomized or observational studies.
  • Included studies on AD dementia and MCI using neuroimaging, excluding other dementia types.

Main Results:

  • The study synthesizes evidence on neuroimaging modalities and data analysis techniques for predicting MCI to AD conversion.
  • It provides an updated overview of methods used to detect brain changes during the conversion process.

Conclusions:

  • The findings will clarify the extent of evidence for predicting MCI to AD dementia conversion.
  • This synthesis aids in understanding the role of neuroimaging and machine learning in early AD detection.